Lipitor and Piperacillin and tazobactam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lipitor (atorvastatin calcium) and Piperacillin and tazobactam (piperacillin sodium; tazobactam sodium). Common drug interactions include anxiety disorder among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Lipitor and Piperacillin and tazobactam. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Lipitor?

Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,047 Lipitor users. Check the latest studies of Lipitor.

What is Piperacillin and tazobactam?

Piperacillin and tazobactam has active ingredients of piperacillin sodium; tazobactam sodium. eHealthMe is studying from 12,660 Piperacillin and tazobactam users. Check the latest studies of Piperacillin and tazobactam.



On Jul, 12, 2026

48 people who take Lipitor and Piperacillin and tazobactam together, and have interactions are studied.

Lipitor and Piperacillin and tazobactam drug interactions.

What are the common drug interactions of Lipitor and Piperacillin And Tazobactam, by gender? *:

female:

  1. Anxiety disorder
  2. Blood pressure systolic decreased
  3. Cardiac failure
  4. Cellulitis (infection under the skin)
  5. Chills (felling of cold)
  6. Discomfort
  7. Dyspnoea (difficult or laboured respiration)
  8. Dyspnoea exertional (breathlessness or shortness of breath)
  9. Facial pain
  10. Headache (pain in head)

male:

  1. Pyrexia (fever)
  2. Pneumonia
  3. Blood bilirubin increased
  4. Hypotension (abnormally low blood pressure)
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Acute myocardial infarction (acute heart attack)
  7. Alanine aminotransferase increased
  8. Asthenia (weakness)
  9. Blood pressure decreased
  10. Bradycardia (abnormally slow heart action)

What are the common drug interactions of Lipitor and Piperacillin And Tazobactam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Epididymitis (pain in the scrotum or testicle)
  2. Kidney transplant rejection
  3. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  4. Procedural pain
  5. Pyrexia (fever)
  6. Haemoglobin decreased

40-49:

  1. Abdominal pain
  2. Hypokalaemia (low potassium)
  3. Toxic skin eruption (skin breakdown due to toxic substance)

50-59:

  1. Chills (felling of cold)
  2. Dermatitis allergic (inflammation of the skin due allergic reaction)
  3. Disease progression
  4. Dyspnoea (difficult or laboured respiration)
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Headache (pain in head)
  7. Hypoxia (low oxygen in tissues)
  8. Lung disorder (lung disease)
  9. Nausea (feeling of having an urge to vomit)
  10. Oxygen saturation decreased

60+:

  1. Pneumonia
  2. Acute respiratory failure
  3. Asthenia (weakness)
  4. Blood pressure decreased
  5. Bradycardia (abnormally slow heart action)
  6. Cardiac failure
  7. Cardiogenic shock (inadequate circulation of blood)
  8. Chronic respiratory failure
  9. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  10. Death

What are the existing conditions these people have? *

  1. Pneumonia: 11 people, 22.92%
  2. High Blood Pressure: 11 people, 22.92%
  3. Infection: 9 people, 18.75%
  4. Pain: 6 people, 12.50%
  5. Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 10.42%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 10.42%
  7. Diabetes: 4 people, 8.33%
  8. Urination - Excessive Volume: 4 people, 8.33%
  9. Lipids Increased (excess lipid in body): 3 people, 6.25%
  10. Sedation: 3 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Lipitor and Piperacillin and tazobactam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lipitor and Piperacillin and tazobactam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lipitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Piperacillin and tazobactam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lipitor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Piperacillin and tazobactam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium and piperacillin sodium; tazobactam sodium (the active ingredients of Lipitor and Piperacillin and tazobactam, respectively), and Lipitor and Piperacillin and tazobactam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: